Skip to main content
Top
Metadata
Title
Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor
Authors
Xiang-Yang Wang
Ying Li
Masoud H. Manjili
Elizabeth A. Repasky
Drew M. Pardoll
John R. Subjeck
Publication date
01-08-2002
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 6/2002
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-002-0287-1

Other articles of this Issue 6/2002

Cancer Immunology, Immunotherapy 6/2002 Go to the issue

Letter to the Editors

Immunogenicity of WT-1 peptides

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine